These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12618649)

  • 1. [Clinical presentation of immune mediated cerebellar ataxia].
    Honnorat J; Trouillas P
    Rev Neurol (Paris); 2003 Jan; 159(1):11-22. PubMed ID: 12618649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation of immune-mediated cerebellar ataxia.
    Demarquay G; Honnorat J
    Rev Neurol (Paris); 2011 May; 167(5):408-17. PubMed ID: 21055784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
    Mitoma H; Nanri K
    Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paraneoplastic cerebellar degeneration].
    Sakai K
    Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar ataxia associated with anti-Hu antibodies and benign ganglioneuroma.
    Fancellu R; Corsini E; Bernardi G; Buzzo P; Ferrari ML; Lamantea E; Garaventa A; Truini M; Salvarani S
    Funct Neurol; 2014; 29(4):277-80. PubMed ID: 25764259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
    Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.
    Sillevis Smitt P; Kinoshita A; De Leeuw B; Moll W; Coesmans M; Jaarsma D; Henzen-Logmans S; Vecht C; De Zeeuw C; Sekiyama N; Nakanishi S; Shigemoto R
    N Engl J Med; 2000 Jan; 342(1):21-7. PubMed ID: 10620645
    [No Abstract]   [Full Text] [Related]  

  • 10. New autoantibody mediated disorders of the central nervous system.
    Lang B; Dale RC; Vincent A
    Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia.
    Balegno S; Ceroni M; Corato M; Franciotta D; Giometto B; Marinu-Aktipu K; Nano R
    Anticancer Res; 2005; 25(5):3211-4. PubMed ID: 16101129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar ataxia as a possible organ-specific autoimmune disease.
    Hadjivassiliou M; Boscolo S; Tongiorgi E; Grünewald RA; Sharrack B; Sanders DS; Woodroofe N; Davies-Jones GA
    Mov Disord; 2008 Jul; 23(10):1370-7. PubMed ID: 18546342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated acquired ataxias.
    Hadjivassiliou M
    Handb Clin Neurol; 2012; 103():189-99. PubMed ID: 21827889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-neuronal antibodies and central nervous system diseases: contribution to diagnosis and pathophysiology].
    Antoine JC; Honnorat J
    Rev Neurol (Paris); 2000 Jan; 156(1):23-33. PubMed ID: 10693255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
    Mitoma H; Manto M; Hampe CS
    Curr Neuropharmacol; 2019; 17(1):33-58. PubMed ID: 30221603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.
    Hadjivassiliou M
    CNS Neurol Disord Drug Targets; 2019; 18(6):423-431. PubMed ID: 29268693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome antibodies in paraneoplastic cerebellar degeneration.
    Storstein A; Knudsen A; Vedeler CA
    J Neuroimmunol; 2005 Aug; 165(1-2):172-8. PubMed ID: 15964637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms.
    Mitoma H; Manto M
    J Neurol; 2024 Oct; 271(10):7046-7053. PubMed ID: 39052041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.